In the past decade, the use of Patient Reported Outcome Measures (PROMs) has become a prominent topic in healthcare innovation in cancer care and the direct measurement of patients’ experiences with cancer.
Patient Reported outcomes give physicians new insights into various clinical aspects of oncology and provide important information throughout the course of a therapy.1
Implementation of Patient Reported Outcome Measurements in routine chemotherapy was demonstrated to lengthen median survival in metastatic cancer patients. Potential mechanisms of action are that symptoms possibly leading to adverse events were detected and responded to earlier, and that patients could tolerate chemotherapy longer.2
Quality of life for patients with metastatic cancer can significantly improve with adequate treatment of symptoms and side effects.3PROMs are therefore a deciding factor in the delivery of high-quality cancer care.
Find out what we offer in the field of oncology for:
“With patient-reported outcome measures at our breast cancer centre at the Charité, we now quickly receive more relevant information from our patients themselves!”
Prof. Dr. med. Jens-Uwe Blohmer – Director, Department of Gynaecology and Breast Cancer Center, Charité University Hospital Berlin
To ensure the highest standard of data collection, we offer condition-specific outcome-sets and can support you with the implementation of scientifically validated and time-tested instruments to collect Patient Reported Outcomes:
Patient-Reported Outcome Measures (PROMs)
heartbeat PRO Sets
(Patient- & Clinician-reported)
Clinician-Reported Outcome Measures
*upcoming